FibroBiologics Secures Australian Patent for Breakthrough Cartilage Regeneration Method

FibroBiologics, , a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential...

April 12, 2024 | Friday | News
Blue Wolf Capital Partners to Acquire Seven European Manufacturing and Development Facilities from Recipharm

    The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France...

April 03, 2024 | Wednesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
Abzena's $5 Million Investment Boosts Bristol Facility's Bioconjugation Capabilities and Enhances Operational Efficiency

 The $5 million investment in expanded laboratory space, new equipment, and facility upgrades, builds upon the site’s existing bioconjugation ca...

March 28, 2024 | Thursday | News
SCHOTT Pharma to Establish State-of-the-Art Facility in Wilson, North Carolina, Bolstering U.S. Pharmaceutical Supply Chain

   SCHOTT Pharma announces plans to solidify its footprint in the United States with the establishment of a cutting-edge facility in Wilson, Nor...

March 19, 2024 | Tuesday | News
Biotech Lobbying Powerhouse BIO Ends Association with WuXi AppTec Amid Security Crackdown

Biotechnology Innovation Organization (BIO), a leading lobbying group in Washington, D.C., announced its decision to sever ties with WuXi AppTec, a Chinese...

March 15, 2024 | Friday | Reports
Hovione Adopts Micellar Tech for Greener API Production

Hovione has entered into a license agreement with Dragonfly Technologies, Inc. to offer its customers the breakthrough micellar technology developed by...

March 08, 2024 | Friday | News
CoreRx, Inc. Set to Acquire Societal CDMO, Bolstering CDMO Sector Capabilities

This strategic acquisition marks a pivotal step towards creating a combined entity with expanded capabilities and a robust service offering that spans from...

February 29, 2024 | Thursday | News
Vetter Pioneers Market Launch of Eight Innovative Drug Products in 2023

Vetter, a globally recognized contract development and manufacturing organization (CDMO), proudly announces the successful market introduction of eight cus...

February 14, 2024 | Wednesday | News
Catalent's Meteoric Rise as Novo Holdings Makes Groundbreaking Acquisition

In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....

February 08, 2024 | Thursday | News
Antitrust Showdown Looms Over Novo-Catalent Mega Deal!

  In a bold move, Ricks emphasized the urgency for financial regulators to scrutinize the deal, pointing out Catalent's extensive client base, compri...

February 08, 2024 | Thursday | News
Wegovy Producer Catalent Snapped Up in $16.5 Billion Deal by Novo Holdings

In a strategic shift that promises to redefine the pharmaceutical industry, Novo Holdings, the investment arm of Novo Nordisk's parent foundation, has unve...

February 05, 2024 | Monday | News
Biovian and 3P Biopharmaceuticals Form 3PBIOVIAN, a Pan-European Biologics Powerhouse

Backed by their common shareholder, Keensight Capital, one of the leading private equity funds dedicated to pan-European Growth Buyout[] investments, the c...

February 02, 2024 | Friday | News
Bora Pharmaceuticals Acquires Upsher-Smith for $210M to Drive Global Growth

Upsher-Smith, founded in 1919 and owned by Sawai since 2017, has a diversified portfolio of 48 generic products with manufacturing facilities in Plymouth a...

January 17, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in